e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison
M. Skronski, P. Jagus, A. Szpechcinski, R. Struniawski, J. Chorostowska-Wynimko (Warsaw, Poland)
Source:
Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session:
Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session type:
E-Communication Session
Number:
3546
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Skronski, P. Jagus, A. Szpechcinski, R. Struniawski, J. Chorostowska-Wynimko (Warsaw, Poland). Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison. Eur Respir J 2010; 36: Suppl. 54, 3546
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Pulmonary sarcoidosis
Related content which might interest you:
Evaluation of PNA-LNA PCR clamp method sensitivity for detection of key EGFR gene exon 19 and exon 21 mutations
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells content
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Evaluation of highly sensitive PNA-LNA PCR clamp method for EGFR L858R mutation detection in lung adenocarcinoma patients
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Detection of isoniazid resistance mutations in
Mycobacterium tuberculosis
by use of sequencing, PCR-RFLP and TaqMan probes
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by Eprobe-PCR method
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Target other gene point mutations: HER2 and rare EGFR mutations
Source: ERS Research Seminar
Year: 2015
Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Detection of rifampin resistance mutations in
Mycobacterium tuberculosis
by use of sequencing, molecular beacons and taqman probes
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
Noninvasive detection of
EGFR
T790M mutation in gefitinib resistant non-small cell lung cancer using mutant-enriched PCR
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Clinical value of IS
6110
-based loop-mediated isothermal amplification (IS
6110
-LAMP) for direct detection of
Mycobacterium tuberculosis
complex in respiratory specimens
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
The detection of EGFR mutations in liquid biopsy by allele-specific qPCR – the comparative evaluation of two common diagnostic tests
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
LATE-BREAKING ABSTRACT: Reliability of EGFR mutations detection in NSCLC brain metastases by two different allele-specific PCR methods
Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Year: 2012
Frequency and clinical-tomographic characterization of NSCLC with T790M mutation to TKI progression.
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
Rapid detection of
M. tuberculosis
gene mutations associated with drug resistance by modified allele-specific real-time PCR
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006
RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Development a set of reagents for real-time PCR diagnostics and surveillance of infections caused by
B. pertussis
,
B. parapertussis
and
B. bronchiseptica
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept